Medway Community Healthcare Medway NHS Trust Foundation Trust
Medway Clinical Commissioning Group Swale Clinical Commissioning Group

2.4.1.4 Thiazide and related diuretics

Metolazone

Caution:
•There are key safety concerns around significant variation in bioavailability between alternative preparations of Metolazone.
•For new and existing patients, it is advised that Metolazone is prescribed by its licensed brand name Xaqua®.
•Please note: Xaqua 5mg is approximately equivalent to 10mg unlicensed metolazone, these products are not interchangeable. The starting dose for Xaqua should be 2.5mg daily.
•It is advised that specialists should manage the switching of patients established on an unlicensed metolazone preparation, to the licensed brand Xaqua® and that all subsequent prescriptions of Metolazone be brand specific.

For Metolazone (Xaqua ®) prescribing position statement & Patient Information Click Here

Metolazone (Xaqua ®)MHRA  Drug Safety Update Click Here

Pack
28 tablet
500 tablet
Pack
100 tablet
1000 tablet
28 tablet
500 tablet
Pack
100 tablet
28 tablet
Pack
100 tablet
28 tablet
30 tablet
500 tablet
Pack
28 tablet
30 tablet
56 tablet
60 tablet

Metolazone should be initiated by Cardiology or Renal specialists as branded, Xaqua® 5mg tablets -must be prescribed by brand - should not be prescribed in generic form as this is non formulary.

Pack
20 tablet
  • First Line Choice
  • On Formulary
  • Specialist Initiation Only
  • Hospital Only
  • KMPT Initiation Only
  •